GABA Transporter 1 (GAT1) (Middle Region) Peptid
GAT1
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN984039
Kurzübersicht für GABA Transporter 1 (GAT1) (Middle Region) Peptid (ABIN984039)
Target
SLC6A1 (GAT1)
(GABA Transporter 1 (GAT1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SLC6A1 antibody (Catalog #: ARP43834_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SLC6A1 (GAT1) (GABA Transporter 1 (GAT1))
-
Hintergrund
-
SLC6A1 terminates the action of GABA by its high affinity sodium-dependent reuptake into presynaptic terminals. This protein is the target of psychomotor stimulants such as amphetamines or cocaine.
Alias Symbols: GABATHG, GABATR, GAT1
Protein Interaction Partner: STX1A,STX1A
Protein Size: 599 -
Molekulargewicht
- 67 kDa
-
Gen-ID
- 6529
-
NCBI Accession
- NM_003042, NP_003033
-
UniProt
- P30531
Target
-
Sie sind hier:
